Work

Real‐world evidence to support regulatory decision making: New or expanded medical product indications

Year: 2021

Type: review

Source: Pharmacoepidemiology and Drug Safety

DOI: 10.1002/pds.5222

Authors: Jessica M. Franklin, Kai‐Li Liaw, Solomon Iyasu, Cathy W. Critchlow, Nancy A. Dreyer

Institutions: Brigham and Women's Hospital, Harvard University, Merck & Co., Inc., Rahway, NJ, USA (United States), Amgen (United States)

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Heart, Lung, and Blood Institute

Award: Randomized Cardiovascular Trials Duplicated Using Prospective Longitudinal Insurance Claims: Applying Techniques of Epidemiology (RCT DUPLICATE)

OpenAlex ID: W3134151851

FWCI: 1.027

Cites: 54

Cited by: 34

Related to: 10